Chronic heart failure (HFrEF)
Protocol · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Long-term management of heart failure with reduced ejection fraction (LVEF ≤ 40%). Aim to reduce symptoms and hospitalisation AND prolong survival — build the four pillars of guideline-directed therapy early and up-titrate, while treating the cause and comorbidities.
Assessment
Investigations
- Confirm HFrEF: echo (LVEF ≤ 40%, chamber size, valves, wall motion); ECG (QRS width for CRT, AF, prior MI); NT-proBNP for diagnosis (do NOT routinely use serial levels to guide therapy — GUIDE-IT negative)
- Find & treat the cause: ischaemia (angiography/viability — revascularise if LVEF ≤ 35% with suitable CAD), valve disease, arrhythmia-induced, alcohol, sarcoid/amyloid, thyroid, genetic/familial cardiomyopathy
- Baseline & monitoring: U&E/eGFR and BP before and during up-titration (RAASi/MRA/diuretic), FBC + iron studies (treat iron deficiency), HbA1c/TFTs
- Review and STOP drugs that worsen HF — NSAIDs, most calcium-channel blockers, thiazolidinediones (pioglitazone), class I/III antiarrhythmics
Management
- Four pillars of GDMT — start early, use low doses of all four, then up-titrate: (1) ARNI (sacubitril–valsartan) — or ACE inhibitor / ARB if ARNI unsuitable; (2) beta-blocker (bisoprolol, carvedilol or metoprolol succinate); (3) MRA (spironolactone or eplerenone); (4) SGLT2 inhibitor (dapagliflozin or empagliflozin)
- Loop diuretic (furosemide) for congestion — symptom relief only, at the lowest dose that keeps the patient euvolaemic (little survival benefit)
- Selected add-ons: hydralazine + nitrate (esp. self-identified Black patients, or if RAASi not tolerated); ivabradine (sinus rate ≥ 70 on max beta-blocker); digoxin for symptoms/rate
- Devices when on optimal therapy: ICD for primary prevention if LVEF ≤ 35%; CRT if LVEF ≤ 35% + LBBB/QRS ≥ 130–150 ms
- Self-management + prevention: daily weights, sodium < 3 g/day (fluid restrict only in refractory/hyponatraemia), cardiac rehab (NYHA II–III), flu + pneumococcal vaccination
Disposition
Multidisciplinary HF team + early cardiology referral; refer promptly for persistent/worsening symptoms or symptomatic hypotension. Refractory (stage D) → advanced therapies: IV inotropes/vasodilators, mechanical circulatory support (LVAD), transplant, and palliative care. Not for routine antiplatelet/anticoagulation in sinus rhythm without another indication.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.